Gainers
- Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading volume for this security ended up closing at 14.2 million shares, which is 369.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $13.6 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 9.28% to $0.95. At the close, NeuroBo Pharmaceuticals's trading volume reached 232.9K shares. This is 119.9% of its average volume over the last 100 days. The company's market cap stands at $25.3 million.
- ASLAN Pharma (NASDAQ:ASLN) shares rose 9.14% to $0.82. The market value of their outstanding shares is at $57.1 million.
- Renalytix (NASDAQ:RNLX) stock moved upwards by 7.87% to $6.3. The company's market cap stands at $235.4 million.
- Calyxt (NASDAQ:CLXT) stock rose 6.06% to $0.7. The company's market cap stands at $29.9 million.
- aTyr Pharma (NASDAQ:LIFE) shares increased by 6.06% to $5.25. The market value of their outstanding shares is at $145.9 million.
Losers
- Nektar Therapeutics (NASDAQ:NKTR) shares fell 22.1% to $4.8 during Thursday's after-market session. Nektar Therapeutics's trading volume hit 1.3 million shares by close, accounting for 41.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $894.1 million.
- InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 8.95% to $0.27. This security traded at a volume of 80.1K shares come close, making up 15.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
- Evoke Pharma (NASDAQ:EVOK) stock fell 8.36% to $0.35. The market value of their outstanding shares is at $11.6 million.
- Avenue Therapeutics (NASDAQ:ATXI) stock declined by 6.64% to $0.47. The company's market cap stands at $10.3 million.
- Galectin Therapeutics (NASDAQ:GALT) shares declined by 6.33% to $1.63. This security traded at a volume of 519.1K shares come close, making up 525.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $96.7 million.
- Immunogen (NASDAQ:IMGN) shares decreased by 5.43% to $5.06. The company's market cap stands at $1.1 billion. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
勝者だ
- カレド生物科学ナスダック(KLDO:KLDO)株価は木曜日盤後に10.3%上昇し、0.32ドルに上昇した。この証券の今日の出来高は1,420万株で、過去100日の平均出来高の369.4%だった。彼らの流通株の時価は1360万ドルだ
- NeuroBo製薬ナスダック(Sequoia Capital:NRBO)株価は9.28%から0.95ドル上昇した。終値ではNeuroBo製薬の出来高は232.9万株に達した。これは過去100日の平均出来高の119.9である.同社の時価は2530万ドルである
- アスラン製薬会社ナスダック(Sequoia Capital:ASLN)株価は9.14%上昇し、0.82ドルに上昇した。彼らの流通株の時価は5710万ドルだった
- Renalytixナスダック(Tmall:RNLX)株価は7.87%上昇し、6.3ドルまで上昇した。同社の時価は2.354億ドル
- Calyxtナスダック(Tmall:CLXT)株価は6.06%上昇し、0.7ドルに上昇した。同社の時価は2990万ドル
- アテル製薬会社ナスダック:LIFE)株価は6.06%上昇し、5.25ドルになった。彼らの流通株の時価は1兆459億ドルだった
敗者は
- Nektar治療会社はナスダック株価は木曜日盤後に22.1%下落し、4.8ドルになった。Nektar Treateuticsの出来高は終値までに130万株に達し,過去100日間の平均出来高の41.9%を占めた。彼らの流通株の時価は8.941億ドルだった
- 体内治療Hldgナスダック株価は8.95%下落し、0.27ドルになった。この証券の出来高は80.1 K株で,過去100日間の平均出来高の15.6%に近い。彼らの流通株の時価は940万ドルだ
- 薬業を呼び起こすナスダック:EVOK)株価は8.36%下落し、0.35ドルになった。彼らの流通株の時価は1160万ドルだ
- 大通り治療会社ナスダック(Tmall:ATXI)株価は6.64%下落し、0.47ドルになった。同社の時価は1,030万ドルである
- Galectin治療薬ナスダック株コード:GALT)株価は6.33%下落し、1.63ドルになった。この証券の出来高は519.1 K株で、過去100日の平均出来高の525.0%に近い。彼らの流通株の時価は9670万ドルだ
- 免疫遺伝子ナスダック(Tmall:IMGN)株価は5.43%下落し、5.06ドルになった。同社の時価は11億ドルまた会いましょう
本稿では,Benzingaの自動コンテンツエンジンから生成され,編集査読される.